Gaurav Gupta has a theory about how Indians will manage their health in the coming decade, and it involves a ₹14,500 titanium ring, continuous glucose monitors, and an acquisition of a Swedish skincare brand that—until recently—few had heard of.
The former Zomato co-founder's wellness venture, Gabit, has pulled in ₹36.2 crore (roughly $3.7 million) through an angel-led pre-Series A round, regulatory filings reviewed by Inc42 indicate. The capital arrived in two tranches during the spring, according to board approvals dated March and April, pushing Gabit's total disclosed funding north of $12.7 million. Not bad for a company that only legally incorporated in March 2022.
What's striking isn't just the money—angel rounds of this size have become routine in India's startup corridors—but the sprawling ambition behind it. Gabit is attempting something that would exhaust most early-stage companies: simultaneously building hardware (a smart ring and scale), running medical programs (diabetes reversal, no less), operating a B2B corporate wellness division, and now, following a December acquisition, selling face serums and supplements. It's the kind of integrated stack that sounds logical on a pitch deck but rarely survives contact with operational reality.
Whether Gupta can pull it off may depend on how quickly India's middle class embraces the quantified-self movement that swept through Silicon Valley a decade ago.
The Angel Chorus
The round drew checks from a familiar cast: Deepak Gupta, Arnab Basu, Manav Gupta, Vilas Dhar, and others whose names appear across India's startup cap tables. Filings show the company issued 4,274 preference shares in March for approximately ₹16.6 crore, then followed with 4,573 shares in April bringing another ₹19.6 crore. The shares carried a face value of ₹100 with a hefty ₹38,786 premium, though the company hasn't disclosed a formal valuation—a detail that might matter more if this were a later-stage round.
This marks Gabit's third known fundraise. The Gurugram outfit, operating legally as Betterlife Horizons Pvt Ltd, secured $9.5 million in seed capital back in 2023 from Norwest Venture Partners. That round included a marquee list of individual backers: Zomato's Deepinder Goyal (a natural ally, given Gupta's history there), CRED's Kunal Shah, and Amazon India's Amit Agarwal. Then came a second, undisclosed angel round last September featuring Bollywood actor Ranbir Kapoor and rapper Badshah—the kind of celebrity participation that generates headlines, if not always strategic value.
Hardware Meets Chronic Disease
At the center of Gabit's pitch sits its titanium smart ring, priced at ₹14,500. The company bills it as India's first ring addressing all four wellness pillars: fitness, nutrition, sleep, and stress. The device monitors heart rate, heart rate variability, blood oxygen levels, skin temperature, and VO2 max, running seven to ten days on a charge. Crucially, it doesn't require a subscription—a pointed departure from Oura's model, which dominated the category in Western markets before competitors proliferated.
But the ring is only the entry point. Perhaps recognizing that hardware margins alone won't build a sustainable business, Gabit layered on continuous glucose monitoring programs explicitly targeting diabetes and pre-diabetes reversal. The 12-month Pro packages bundle CGM devices with doctor consultations, personalized coaching, and nutrition plans. Monthly costs range from approximately ₹2,696 to ₹3,420 depending on which program you select—not cheap, but positioned below what many endocrinologists charge for comprehensive diabetes management in India's private healthcare system.
The platform also includes a smart scale and blood work integration, all feeding into what Gabit describes as AI-powered coaching through its app. How sophisticated that AI actually is remains an open question—startups routinely oversell algorithmic capabilities—but the data integration play makes sense on paper.
The Skincare Detour
Then there's the Näck acquisition. Last December, Gabit bought the clean-label nutrition and skincare brand, which had Swedish origins and a modest following in India. Suddenly, Gabit's direct-to-consumer catalog expanded to include cleansers, serums, moisturizers, and sunscreen alongside protein powders and supplements.
It's an odd pivot, or maybe not. Beauty and wellness increasingly occupy the same mental space for consumers, and the skincare market in India has proven lucrative for brands that can navigate distribution and trust-building. Still, it adds operational complexity to a company that already spans hardware manufacturing, medical program delivery, and corporate B2B partnerships. One wonders if Gupta and co-founder Arpana Shahi—formerly of SkillTap—aren't stretching themselves thin.
Fighting for Second Place
Within India's embryonic smart ring market, Gabit claims the number-two spot. IDC India's tracker data, reported in April, pegged the company's market share at roughly 18.3% based on 2025 shipment figures. Ultrahuman, the category leader backed by Blume Ventures and Steadview Capital, commands approximately 30.4%.
Context matters here: smart rings remain a niche within a niche. India's broader wearables market actually contracted 4% year-over-year in 2025, declining to 114.2 million units as smartwatch shipments fell 17.6%. Fitness bands have saturated the affordable segment, and consumers haven't yet demonstrated they need another device. Rings occupy an uncertain middle ground—more subtle than a watch, potentially more accurate, but also easier to forget you're wearing, which cuts both ways for behavior change.
Gabit did pick up an "Best Smart Ring Brand" award at the NDTV Gadgets360 event in April, the kind of recognition that helps retail placement but doesn't necessarily translate to sales velocity. Market research outfits project India's smart wearables sector could reach $11.39 billion by 2034, growing at a 16.4% compound annual rate. Those forecasts, naturally, assume sustained consumer interest and distribution improvements that haven't fully materialized yet.
The Timing Question
Inc42's reporting suggests the new capital will fund expansion across Gabit's wearables, nutrition, and skincare verticals. Whether that's wise—or whether focus might serve the company better—depends on your view of market windows.
The macro case for preventive health in India is hard to argue against. ICMR-INDIAB research published across 2023 and 2024 documented double-digit diabetes prevalence with tens of millions more in the pre-diabetes category. If even a fraction of that population shifts toward continuous monitoring and structured reversal programs, the addressable market is enormous.
But execution is another matter entirely. Building consumer hardware at scale requires supply chain sophistication most startups lack. Medical programs demand clinical credibility and regulatory navigation. Skincare and supplements face fierce incumbents and trust barriers. Doing all three simultaneously while maintaining quality and unit economics? That's an operational high-wire act.
Gupta has enlisted Dr. Romit Bhattacharya—MD, affiliated with Massachusetts General Hospital, Harvard Medical School, and the Broad Institute—as scientific advisor for the ring. That's the kind of credential that matters in conversations with institutional buyers and skeptical physicians, assuming Bhattacharya actively participates rather than lending his name from afar.
The Road Ahead
Gabit's LinkedIn profile lists 11 to 50 employees, a range so wide it's almost meaningless but suggests the company remains relatively lean. Headquarters sit in Gurgaon, the corporate satellite that sprouted alongside Delhi's expansion. The company's most recent annual general meeting took place in September 2025, according to corporate records.
What happens next will test whether Gupta's integrated wellness thesis holds together or splinters under its own complexity. The capital gives him runway to find out. Meanwhile, India's wellness-curious middle class will decide whether they actually want health management bundled into a single platform—or whether they'll continue patching together solutions from specialists who do one thing exceptionally well.
For now, Gabit has its titanium ring, its glucose monitors, its Swedish face cream, and a check from a roomful of angels betting the pieces will cohere into something larger. Which, in startup parlance, means the real story hasn't been written yet.
